Ce fi derocol Is an Effective Topical Monotherapy for Experimental Extensively Drug-Resistant Pseudomonas aeruginosa KeratitisOPHTHALMOLOGY SCIENCEIF4.62024-07-013OAAI
Cyclopentenylcytosine (CPE-C): In Vitro and In Vivo Evaluation as an Antiviral against Adenoviral Ocular InfectionsMOLECULESIF4.62023-06-291OAAI
Antigen presentation deficiency and mesenchymal differentiation underlie resistance to immunotherapy in the murine syngeneic CT2A tumor modelCANCER RESEARCHIF16.62023-04-040PRE
Ranpirnase (OKG-0301), a Novel Ribonuclease, Demonstrates Antiviral Activity against Adenovirus in the Ad5/NZW Rabbit Ocular Replication ModelPATHOGENSIF3.32022-12-071OAAI
Topical Astodrimer Sodium, a Non-Toxic Polyanionic Dendrimer, Demonstrates Antiviral Activity in an Experimental Ocular Adenovirus Infection ModelMOLECULESIF4.62021-06-058OAAI
Filociclovir Is an Active Antiviral Agent against Ocular Adenovirus Isolates In Vitro and in the Ad5/NZW Rabbit Ocular ModelPHARMACEUTICALSIF4.82021-03-267OAAI
The In Vitro and In Vivo Evaluation of ddC as a Topical Antiviral for Ocular Adenovirus InfectionsINVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCEIF4.72009-11-0120PREAI
N-chlorotaurine is an effective antiviral agent against adenovirus in vitro and in the Ad5/NZW rabbit ocular modelINVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCEIF4.72006-05-0143PREAI
Intracarneral Vigamox® (moxifloxacin 0.5%) is not effective in preventing endophthalmitis in a rabbit model -: ReplyAMERICAN JOURNAL OF OPHTHALMOLOGYIF4.22006-04-011PREAI
An ophthalmologist's guide to understanding antibiotic susceptibility and minimum inhibitory concentration dataOPHTHALMOLOGYIF9.52005-11-0174PREAI
Adenovirus-directed ocular innate immunity:: The role of conjunctival defensin-like chemokines (IP-10, I-TAC) and phagocytic human defensin-αINVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCEIF4.72005-10-0135PREAI
Intracameral Vigamox® (moxifloxacin 0.5%) is non-toxic and effective in preventing endophthalmitis in a rabbit modelAMERICAN JOURNAL OF OPHTHALMOLOGYIF4.22005-09-0159PREAI
The successful treatment of gatifloxacin-resistant Staphylococcus aureus keratitis with Zymar® (Gatifloxacin 0.3%) in a NZW rabbit modelAMERICAN JOURNAL OF OPHTHALMOLOGYIF4.22005-05-0159PREAI
Topical prophylaxis with moxifloxacin prevents endophthalmitis in a rabbit modelAMERICAN JOURNAL OF OPHTHALMOLOGYIF4.22004-07-0166PREAI
Experimental laser-assisted in situ keratomileusis induces the reactivation of latent herpes simplex virusAMERICAN JOURNAL OF OPHTHALMOLOGYIF4.22001-04-0131PREAI